Posted on

Addressing Mental Health in CF

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Anxiety and depression in cystic fibrosis — who do these conditions affect? How much do they influence patient health? How can clinicians identify and manage them? What evidence-based interventions have been shown to work?

In this issue, Dr. Anna Georgiopoulos, Assistant Professor of Psychiatry, Part-Time, Harvard Medical School and Consulting Psychiatrist, Massachusetts General Hospital Cystic Fibrosis Program, takes us to the clinic to answer these questions that can be key to the health and well-being of children, adults, and families living with CF.

Podcast (ecystic): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 5/1/2020 – COVID-19: Keeping Up With A Moving Target

In this update for clinicians caring for patients with COVID-19, Sue Hansen, MSN, BSN discusses the basics of mechanical ventilators:

  • Indications for mechanical ventilation
  • Ventilator complications in COVID-19 patients
  • Safely moving patients on ventilators
  • Preventing ventilator-associated pneumonia, and more

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/29/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • Infection Rates – New York vs. Los Angeles
  • Remdesivir trial breaking news
  • COVID-19 transmission data
  • Serology testing: Reliable?
  • Children and COVID-19, and more

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/24/2020 – COVID-19: Keeping Up With A Moving Target

In this new series, Sue Hansen, MSN, RN from UW Medicine at Harborview Medical Center in Seattle provides weekly updates for clinicians caring for patients with COVID-19. She shares practical information for treating COVID-19 patients in the ICU and other settings, and offers recommended best practices. In this episode, she discusses proning:

  • Why we prone, physiological benefits
  • When to and not to prone
  • Complications
  • Special COVID-19 considerations, and more

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/22/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • LA County antibody testing
  • Treatment guidelines from the National Institute of Health
  • NEJM study on two New York City hospitals
  • Data about use of medications for hypertension
  • Update on using plasma to treat patients
  • Reliability of IgM/IgG testing kits
  • And more

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/15/2020 – COVID-19: Keeping Up With A Moving Target

In this week’s update on COVID-19, Dr. Auwaerter gives us a clinical update, answers your questions, and covers topics such as:

  • New CDC guidance
  • Vaccine development
  • Remdesivir for compassionate use
  • Anticoagulation treatment or prophylaxis for hospitalized patients
  • Are providers using ventilators too aggressively?
  • Antihypertensives and their role in virus acquisition and complications
  • And more…

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Treating HCV in PWID: Best Practices

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hepatitis C has become “curable” for >90% of those infected. But while universal HCV elimination is medically possible, this goal is compromised by certain populations who remain underscreened, undertreated, and underserved and continue to spread the virus. One such population is people who inject drugs (PWID).   

In this issue, Dr. Brianna Norton and Dr. Matthew Akiyama from the Albert Einstein College of Medicine analyze the most important data to explain how substance use impacts adherence and the risk of HCV reinfection.

Podcast (eviralhepatitis): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/8/2020 – COVID-19: Keeping Up With A Moving Target

In this week’s update on COVID-19, Dr. Paul Auwaerter from Johns Hopkins School of Medicine gives us a clinical update, answers your questions, and covers topics such as:

  • New CDC guidelines on wearing masks.
  • The real-life implications of the study showing how long COVID-19 survives on surfaces.
  • Are reports of readmission to the hospital due to reinfection or testing errors?
  • Do patients already taking hydroxychloroquine for lupus or RA have any protection from COVID-19?

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Increasing PrEP Uptake in Women

Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers? 

In this issue, Dr. Rachel Scott, Scientific Director of Women’s Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers. 

Podcast (ehiv): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

UPDATE 4/1/2020 – COVID-19: Keeping Up With A Moving Target

In this ongoing series, Dr. Paul Auwaerter from Johns Hopkins School of Medicine provides a weekly update on COVID-19 and answers your questions. In this episode, he discusses the latest clinical data and answers your questions on topics such as therapeutics, chest X-rays and CTs, immunocompromised patients, & antibody and viral oropharyngeal testing.

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS